Shenghui Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Shenghui Liang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Jia Zhao
Life Sciences Institute, Departments of Cellular & Physiological Sciences and Surgery, The University of British Columbia, Vancouver, BC, Canada
3 shared publications Timothy J. Kieffer
2 shared publications- André Bégin-Drolet
Department of mechanical engineering Université Laval Québec City Québec Canada
1 shared publication - Brenden N. Moeun
Department of Chemical Engineering, McGill University, 3610 rue University, Montreal, QC, Canada
1 shared publication - Chao Sun
Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China
1 shared publication - Chao Sun
Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China
1 shared publication
Latest Publications
- 30 October 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (11) , 2143-2160.e7
An ECM-driven mechanotransductive signaling module promotes NKX6.1-enriched human pancreatic progenitor formation
- 30 October 2026
- Published by Elsevier in Developmental Cell
- Vol. 61 (11) , 2143-2160.e7
An ECM-driven mechanotransductive signaling module promotes NKX6.1-enriched human pancreatic progenitor formation
- Open Access
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
ETS Homologous Factor Drives Endothelial Dysfunction in Diabetes-Related Erectile Dysfunction via Regulating SPRY1 Ubiquitination and NOS3 Autophagy
Diabetes mellitus (DM)-related erectile dysfunction (DMED), a prevalent complication of diabetes, is closely associated with endothelial dysfunction. This study investigated the role of E26 transformation-specific homologous factor (Ehf) in mediating endothelial dysfunction in DMED and explored its downstream molecular mechanisms. Rat corpus cavernosum endothelial cells (CCECs) were cultured under high glucose (HG) conditions to simulate a diabetic environment in vitro. Endothelial function was assessed through functional assays, including tube formation and Evans blue permeability tests, following overexpression or knockdown of Ehf, Spry1, or Nos3. Co-immunoprecipitation, ChIP, and dual-luciferase reporter assays were utilized to evaluate molecular interactions and regulatory mechanisms. Ehf expression was significantly elevated in HG-treated CCECs and impaired endothelial function through two distinct mechanisms. First, Ehf stabilized the angiogenesis inhibitor SPRY1 by promoting its acetylation at lysine 300 via ESCO1, thereby reducing its ubiquitination by NEDD4. Second, Ehf induced NOS3 degradation through autophagy by upregulating ATG5 and enhancing the NOS3-NBR1 interaction. These dual mechanisms suppressed angiogenesis and increased vascular permeability, contributing to endothelial dysfunction in DMED. Ehf exacerbates DMED by disrupting penile endothelial function through SPRY1 stabilization and NOS3 degradation. These findings present novel molecular targets for potential therapeutic strategies in DMED.
- 1 January 2026
- Published by XMLink in The World Journal of Men's Health
- Vol. 44
Open AccessETS Homologous Factor Drives Endothelial Dysfunction in Diabetes-Related Erectile Dysfunction via Regulating SPRY1 Ubiquitination and NOS3 Autophagy
Diabetes mellitus (DM)-related erectile dysfunction (DMED), a prevalent complication of diabetes, is closely associated with endothelial dysfunction. This study investigated the role of E26 transformation-specific homologous factor (Ehf) in mediating endothelial dysfunction in DMED and explored its downstream molecular mechanisms. Rat corpus cavernosum endothelial cells (CCECs) were cultured under high glucose (HG) conditions to simulate a diabetic environment in vitro. Endothelial function was assessed through functional assays, including tube formation and Evans blue permeability tests, following overexpression or knockdown of Ehf, Spry1, or Nos3. Co-immunoprecipitation, ChIP, and dual-luciferase reporter assays were utilized to evaluate molecular interactions and regulatory mechanisms. Ehf expression was significantly elevated in HG-treated CCECs and impaired endothelial function through two distinct mechanisms. First, Ehf stabilized the angiogenesis inhibitor SPRY1 by promoting its acetylation at lysine 300 via ESCO1, thereby reducing its ubiquitination by NEDD4. Second, Ehf induced NOS3 degradation through autophagy by upregulating ATG5 and enhancing the NOS3-NBR1 interaction. These dual mechanisms suppressed angiogenesis and increased vascular permeability, contributing to endothelial dysfunction in DMED. Ehf exacerbates DMED by disrupting penile endothelial function through SPRY1 stabilization and NOS3 degradation. These findings present novel molecular targets for potential therapeutic strategies in DMED.
- Open Access
Iterative sacrificial 3D printing and polymer casting to create complex vascular grafts and multi-compartment bioartificial organs
Several emerging strategies to engineer artificial organs employ 3D printing to create vascular templates to provide nutrients and oxygen to immobilized cells. Significant challenges emerge when considering clinical implementation such as immune rejection of allogeneic cell sources, as well as achieving adequate perfusion and integration with endogenous vasculature. We propose a method by which cell-laden hydrogels are molded around ready-made polymeric vascular templates created via 3D printing to create human-scale artificial organs with internal vasculature. We applied this technique to create bioartificial pancreas systems with up to 9 internal flow channels via sacrificial carbohydrate glass 3D printing, porogen-loaded polycarbonate polyurethane dip-coating, followed by casting cell-laden hydrogels around the vascular templates. We optimized porogen size and concentration to maximise the porosity of our scaffolds without compromising mechanical properties, resulting in suture retention strength and compliance respectively matching commercial vascular grafts and native vessels. Bioreactor perfusion studies showed survival and maturation of stem cell derived pancreatic islets without significant differences to traditional suspension culture protocols. Insulin response dynamics were rapid in response to a glucose challenge at the perfusion inlet. Transplantation of the devices as iliac arteriovenous shunts in nondiabetic pigs confirmed safety and patency. These results show promise for the development of an implantable vascularized pancreas for the treatment of type 1 diabetes and demonstrate how bioartificial organs with engineered vascular geometries can be designed for translational applications.
Open AccessIterative sacrificial 3D printing and polymer casting to create complex vascular grafts and multi-compartment bioartificial organs
Several emerging strategies to engineer artificial organs employ 3D printing to create vascular templates to provide nutrients and oxygen to immobilized cells. Significant challenges emerge when considering clinical implementation such as immune rejection of allogeneic cell sources, as well as achieving adequate perfusion and integration with endogenous vasculature. We propose a method by which cell-laden hydrogels are molded around ready-made polymeric vascular templates created via 3D printing to create human-scale artificial organs with internal vasculature. We applied this technique to create bioartificial pancreas systems with up to 9 internal flow channels via sacrificial carbohydrate glass 3D printing, porogen-loaded polycarbonate polyurethane dip-coating, followed by casting cell-laden hydrogels around the vascular templates. We optimized porogen size and concentration to maximise the porosity of our scaffolds without compromising mechanical properties, resulting in suture retention strength and compliance respectively matching commercial vascular grafts and native vessels. Bioreactor perfusion studies showed survival and maturation of stem cell derived pancreatic islets without significant differences to traditional suspension culture protocols. Insulin response dynamics were rapid in response to a glucose challenge at the perfusion inlet. Transplantation of the devices as iliac arteriovenous shunts in nondiabetic pigs confirmed safety and patency. These results show promise for the development of an implantable vascularized pancreas for the treatment of type 1 diabetes and demonstrate how bioartificial organs with engineered vascular geometries can be designed for translational applications.